Healio: Patient engagement with daily pulmonary artery pressure readings shows benefit in HF Please provide your email address to receive an email when new articles are posted on . Engagement in daily pulmonary artery pressure readings may benefit patients with heart failure. Patients made ...
Patient engagement with daily pulmonary artery pressure readings shows benefit in HF New findings reveal pulmonary arterial hypertension may affect the brain early. Learn how inflammation and cognitive decline are linked. AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral pan-rho-associated protein kinase (ROCK) inhibitor, for pulmonary hypertension (PH). Add Yahoo as a preferred source to see more of our stories on Google.
pulmonary artery, Oct. 31—(StatePoint) November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from ... Medscape: Trial Shows Reduced PVR in Adults With HFpEF and Pulmonary Hypertension In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients with combined postcapillary and precapillary pulmonary hypertension and HFpEF.
